Patent · US Expired

Expression control sequences of the P-selectin gene

US5605821A · kind A · utility

3Cited by
4References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 20, 1993
Grant dateFeb 25, 1997
Priority date
Expiry dateAug 20, 2013

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/85
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

DNA molecules and methods for the regulated expression of a gene in endothelial cells or megakaryocytes, are described, wherein the 5' flanking region of the P-selectin gene, or portions thereof, is ligated to the 5' end of a gene. The DNA molecules are also used as probes for screening individuals with abnormal levels of expression of P-selectin, or for production of pharmaceutical compositions to inhibit inflammation by inhibition of expression of P-selectin. These DNA molecules can also be used to identify and isolate previously unknown proteins which are involved in regulation of gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.